The Agenda-Setting for Kidney Disease Open Pilot Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDartmouth-Hitchcock Medical Center

About this trial

The goal of this open pilot is to practice using an intervention and surveys before a larger pilot stepped wedge clinical trial. The intervention the researchers plan to use is Chronic Kidney Disease (CKD) Topics, and it is a structured clinical agenda-setting intervention (SAS), or a customized list of discussion topics. The people the researchers are practicing using the SAS with have advanced CKD (stages 4-5), and many of them live in rural areas. The researchers will practice administering CKD Topics, along with survey questions. By doing the open pilot, the researchers will learn if they need to modify the steps they plan to take in the larger trial.

The main questions the researchers aim to answer are:

* Do the steps for identifying eligible participants work? * Do the steps for administering CKD Topics work? * Do the steps to administer survey questions work?

Eligibility criteria

Qualifiers

Adults >18 years old who have been diagnosed with advanced CKD (stages 4-5).

Care partners, clinicians and staff supporting these CKD patients who are willing and able to provide informed consent

English-speaking

Able to provide informed consent

Disqualifiers

Children under 18 years old will not be included

Non-English-speaking patients and/or care partners

Patients on dialysis

Individuals unable or unwilling to provide informed consent

Trial design

Treatments tested in this trial

  • Chronic Kidney Disease Structured Agenda-Setting Tool

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

Dartmouth-Hitchcock Medical Center

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Dartmouth College

Collaborator